Challenges & Opportunities in Emerging Digital Health Technologies
ISPE
OCTOBER 27, 2022
The FDA describes these products under enforcement discretion if they are intended to inform clinical management for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. IMDRF SaMD Risk Categorization.
52 
Let's personalize your content